Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Ai

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell TransplantationMariam T Nawas, Charalambos Andreadis, Thomas G Martin, et al.
The Journal of Investigative Dermatology|July 1, 2020
Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDACChi-Heng Wu, Chen-Yen Yang, Linlin Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapyRahul Banerjee, Victoria Wang, Chiung-Yu Huang, et al.
Journal of Geriatric Oncology|October 16, 2020
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantationMariam T Nawas, Ying Sheng, Chiung-Yu Huang, et al.
Journal of Geriatric Oncology|June 5, 2014
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipientsJesse W Keller, Charalambos Andreadis, Lloyd E Damon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyJoshua D Brody, Weiyun Z Ai, Debra K Czerwinski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2016
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell TransplantationGabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Blood|November 3, 2011
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 studyYoun H Kim, Dita Gratzinger, Cameron Harrison, et al.
Archives of Pathology & Laboratory Medicine|November 29, 2022
Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell NeoplasmsArzu Saglam, Kunwar Singh, Jyoti Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation StudyKhoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell TransplantationMariam T Nawas, Charalambos Andreadis, Thomas G Martin, et al.
The Journal of Investigative Dermatology|July 1, 2020
Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDACChi-Heng Wu, Chen-Yen Yang, Linlin Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapyRahul Banerjee, Victoria Wang, Chiung-Yu Huang, et al.
Journal of Geriatric Oncology|October 16, 2020
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantationMariam T Nawas, Ying Sheng, Chiung-Yu Huang, et al.
Journal of Geriatric Oncology|June 5, 2014
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipientsJesse W Keller, Charalambos Andreadis, Lloyd E Damon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyJoshua D Brody, Weiyun Z Ai, Debra K Czerwinski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2016
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell TransplantationGabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Blood|November 3, 2011
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 studyYoun H Kim, Dita Gratzinger, Cameron Harrison, et al.
Archives of Pathology & Laboratory Medicine|November 29, 2022
Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell NeoplasmsArzu Saglam, Kunwar Singh, Jyoti Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation StudyKhoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
Pageof 7